HEADER TRANSFERASE 18-FEB-11 2YAC TITLE CRYSTAL STRUCTURE OF POLO-LIKE KINASE 1 IN COMPLEX WITH NMS-P937 COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE PLK1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN RESIDUES 36-345; COMPND 5 SYNONYM: POLO-LIKE KINASE 1, PLK-1, SERINE/THREONINE-PROTEIN KINASE COMPND 6 13, STPK13, PLK1 KINASE; COMPND 7 EC: 2.7.11.21; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 6 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: HIGH FIVE; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS KEYWDS TRANSFERASE, ATP-BINDING, CELL CYCLE, CELL DIVISION, MITOSIS, KEYWDS 2 NUCLEOTIDE-BINDING, NUCLEUS EXPDTA X-RAY DIFFRACTION AUTHOR J.A.BERTRAND,R.T.BOSSI REVDAT 3 03-APR-19 2YAC 1 SOURCE REVDAT 2 11-MAY-11 2YAC 1 JRNL REVDAT 1 06-APR-11 2YAC 0 JRNL AUTH I.BERIA,R.T.BOSSI,M.G.BRASCA,M.CARUSO,W.CECCARELLI,G.FACHIN, JRNL AUTH 2 M.FASOLINI,B.FORTE,F.FIORENTINI,E.PESENTI,D.PEZZETTA, JRNL AUTH 3 H.POSTERI,A.SCOLARO,S.R.DEPAOLINI,B.VALSASINA JRNL TITL NMS-P937, A 4,5-DIHYDRO-1H-PYRAZOLO[4,3-H]QUINAZOLINE JRNL TITL 2 DERIVATIVE AS POTENT AND SELECTIVE POLO-LIKE KINASE 1 JRNL TITL 3 INHIBITOR. JRNL REF BIOORG.MED.CHEM.LETT. V. 21 2969 2011 JRNL REFN ISSN 0960-894X JRNL PMID 21470862 JRNL DOI 10.1016/J.BMCL.2011.03.054 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNX 2005 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN,ACCELRYS REMARK 3 : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA, REMARK 3 : YIP,DZAKULA) REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.84 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1781650.170 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 87.4 REMARK 3 NUMBER OF REFLECTIONS : 18225 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.213 REMARK 3 R VALUE (WORKING SET) : 0.211 REMARK 3 FREE R VALUE : 0.255 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 905 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.008 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.2560 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.2540 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.290 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 905 REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : 0.0100 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 18225 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.34 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 53.80 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1741 REMARK 3 BIN R VALUE (WORKING SET) : 0.3000 REMARK 3 BIN FREE R VALUE : 0.3380 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.10 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 94 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.035 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2353 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 49 REMARK 3 SOLVENT ATOMS : 81 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 19.60 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 38.50 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 8.47000 REMARK 3 B22 (A**2) : 8.47000 REMARK 3 B33 (A**2) : -16.94000 REMARK 3 B12 (A**2) : 5.53000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.28 REMARK 3 ESD FROM SIGMAA (A) : 0.33 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.36 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.36 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.200 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.00 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.840 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.330 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.120 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.190 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.100 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.38 REMARK 3 BSOL : 42.08 REMARK 3 REMARK 3 NCS MODEL : NONE REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : ION.PARAM REMARK 3 PARAMETER FILE 4 : 937.PAR REMARK 3 PARAMETER FILE 5 : TAR.PAR REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : 937.TOP REMARK 3 TOPOLOGY FILE 4 : TAR.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2YAC COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 18-FEB-11. REMARK 100 THE DEPOSITION ID IS D_1290047430. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-MAY-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-3 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.931 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 18237 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 57.640 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 87.8 REMARK 200 DATA REDUNDANCY : 2.800 REMARK 200 R MERGE (I) : 0.08000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.32 REMARK 200 COMPLETENESS FOR SHELL (%) : 52.9 REMARK 200 DATA REDUNDANCY IN SHELL : 2.40 REMARK 200 R MERGE FOR SHELL (I) : 0.56000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: INTERNAL STRUCTURE WITH AMP-PNP REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.53 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.77 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 6.0 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 102.69000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 51.34500 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 51.34500 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 102.69000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2270 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 27520 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -83.7 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 51.34500 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 35 REMARK 465 PRO A 36 REMARK 465 ALA A 37 REMARK 465 LYS A 38 REMARK 465 SER A 330 REMARK 465 SER A 331 REMARK 465 LEU A 332 REMARK 465 ASP A 333 REMARK 465 PRO A 334 REMARK 465 SER A 335 REMARK 465 ASN A 336 REMARK 465 ARG A 337 REMARK 465 LYS A 338 REMARK 465 PRO A 339 REMARK 465 LEU A 340 REMARK 465 THR A 341 REMARK 465 VAL A 342 REMARK 465 LEU A 343 REMARK 465 ASN A 344 REMARK 465 LYS A 345 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 PRO A 329 CA C O CB CG CD REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 48 -34.43 116.85 REMARK 500 ARG A 50 -37.38 82.85 REMARK 500 ASP A 72 99.26 -62.08 REMARK 500 ALA A 73 -30.58 -39.54 REMARK 500 ASP A 74 -77.92 -80.68 REMARK 500 HIS A 110 144.51 -171.88 REMARK 500 ASP A 122 -158.41 -104.64 REMARK 500 ARG A 136 -130.12 61.15 REMARK 500 LYS A 146 -130.87 36.42 REMARK 500 ARG A 175 -4.30 83.91 REMARK 500 ASP A 176 43.05 -142.85 REMARK 500 ASP A 194 87.71 54.60 REMARK 500 ASN A 216 -70.88 -74.05 REMARK 500 LYS A 225 71.88 37.83 REMARK 500 SER A 229 -141.91 -143.50 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 502 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 93 NE2 REMARK 620 2 TLA A 503 O4 85.4 REMARK 620 3 CYS A 212 SG 109.9 78.4 REMARK 620 4 CYS A 255 SG 114.4 141.8 119.8 REMARK 620 N 1 2 3 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 937 A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TLA A 503 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1UMW RELATED DB: PDB REMARK 900 STRUCTURE OF A HUMAN PLK1 POLO-BOX DOMAIN/ PHOSPHOPEPTIDE COMPLEX REMARK 900 RELATED ID: 2V5Q RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF WILD-TYPE PLK-1 KINASE DOMAIN IN COMPLEX WITH REMARK 900 A SELECTIVE DARPIN REMARK 900 RELATED ID: 1Q4K RELATED DB: PDB REMARK 900 THE POLO-BOX DOMAIN OF PLK1 IN COMPLEX WITH A PHOSPHO-PEPTIDE REMARK 900 RELATED ID: 1Q4O RELATED DB: PDB REMARK 900 THE STRUCTURE OF THE POLO BOX DOMAIN OF HUMAN PLK1 DBREF 2YAC A 36 345 UNP P53350 PLK1_HUMAN 36 345 SEQADV 2YAC GLY A 35 UNP P53350 EXPRESSION TAG SEQRES 1 A 311 GLY PRO ALA LYS GLU ILE PRO GLU VAL LEU VAL ASP PRO SEQRES 2 A 311 ARG SER ARG ARG ARG TYR VAL ARG GLY ARG PHE LEU GLY SEQRES 3 A 311 LYS GLY GLY PHE ALA LYS CYS PHE GLU ILE SER ASP ALA SEQRES 4 A 311 ASP THR LYS GLU VAL PHE ALA GLY LYS ILE VAL PRO LYS SEQRES 5 A 311 SER LEU LEU LEU LYS PRO HIS GLN ARG GLU LYS MET SER SEQRES 6 A 311 MET GLU ILE SER ILE HIS ARG SER LEU ALA HIS GLN HIS SEQRES 7 A 311 VAL VAL GLY PHE HIS GLY PHE PHE GLU ASP ASN ASP PHE SEQRES 8 A 311 VAL PHE VAL VAL LEU GLU LEU CYS ARG ARG ARG SER LEU SEQRES 9 A 311 LEU GLU LEU HIS LYS ARG ARG LYS ALA LEU THR GLU PRO SEQRES 10 A 311 GLU ALA ARG TYR TYR LEU ARG GLN ILE VAL LEU GLY CYS SEQRES 11 A 311 GLN TYR LEU HIS ARG ASN ARG VAL ILE HIS ARG ASP LEU SEQRES 12 A 311 LYS LEU GLY ASN LEU PHE LEU ASN GLU ASP LEU GLU VAL SEQRES 13 A 311 LYS ILE GLY ASP PHE GLY LEU ALA THR LYS VAL GLU TYR SEQRES 14 A 311 ASP GLY GLU ARG LYS LYS THR LEU CYS GLY THR PRO ASN SEQRES 15 A 311 TYR ILE ALA PRO GLU VAL LEU SER LYS LYS GLY HIS SER SEQRES 16 A 311 PHE GLU VAL ASP VAL TRP SER ILE GLY CYS ILE MET TYR SEQRES 17 A 311 THR LEU LEU VAL GLY LYS PRO PRO PHE GLU THR SER CYS SEQRES 18 A 311 LEU LYS GLU THR TYR LEU ARG ILE LYS LYS ASN GLU TYR SEQRES 19 A 311 SER ILE PRO LYS HIS ILE ASN PRO VAL ALA ALA SER LEU SEQRES 20 A 311 ILE GLN LYS MET LEU GLN THR ASP PRO THR ALA ARG PRO SEQRES 21 A 311 THR ILE ASN GLU LEU LEU ASN ASP GLU PHE PHE THR SER SEQRES 22 A 311 GLY TYR ILE PRO ALA ARG LEU PRO ILE THR CYS LEU THR SEQRES 23 A 311 ILE PRO PRO ARG PHE SER ILE ALA PRO SER SER LEU ASP SEQRES 24 A 311 PRO SER ASN ARG LYS PRO LEU THR VAL LEU ASN LYS HET 937 A 501 38 HET ZN A 502 1 HET TLA A 503 10 HETNAM 937 1-(2-HYDROXYETHYL)-8-[[5-(4-METHYLPIPERAZIN-1-YL)-2- HETNAM 2 937 (TRIFLUOROMETHOXY)PHENYL]AMINO]-4,5-DIHYDROPYRIMIDO[5, HETNAM 3 937 4-G]INDAZOLE-3-CARBOXAMIDE HETNAM ZN ZINC ION HETNAM TLA L(+)-TARTARIC ACID FORMUL 2 937 C24 H27 F3 N8 O3 FORMUL 3 ZN ZN 2+ FORMUL 4 TLA C4 H6 O6 FORMUL 5 HOH *81(H2 O) HELIX 1 1 SER A 87 LEU A 89 5 3 HELIX 2 2 LYS A 91 SER A 107 1 17 HELIX 3 3 SER A 137 LYS A 146 1 10 HELIX 4 4 THR A 149 ASN A 170 1 22 HELIX 5 5 LYS A 178 GLY A 180 5 3 HELIX 6 6 ALA A 219 SER A 224 1 6 HELIX 7 7 PHE A 230 GLY A 247 1 18 HELIX 8 8 CYS A 255 LYS A 265 1 11 HELIX 9 9 ASN A 275 LEU A 286 1 12 HELIX 10 10 ASP A 289 ARG A 293 5 5 HELIX 11 11 GLU A 298 ASN A 301 5 4 HELIX 12 12 ASP A 302 SER A 307 1 6 HELIX 13 13 PRO A 315 THR A 320 5 6 SHEET 1 AA 6 VAL A 43 VAL A 45 0 SHEET 2 AA 6 ARG A 52 GLY A 62 -1 O TYR A 53 N LEU A 44 SHEET 3 AA 6 ALA A 65 ASP A 72 -1 O ALA A 65 N GLY A 62 SHEET 4 AA 6 VAL A 78 PRO A 85 -1 O PHE A 79 N ILE A 70 SHEET 5 AA 6 PHE A 125 LEU A 130 -1 O VAL A 126 N VAL A 84 SHEET 6 AA 6 PHE A 116 GLU A 121 -1 N HIS A 117 O VAL A 129 SHEET 1 AB 2 VAL A 172 ILE A 173 0 SHEET 2 AB 2 THR A 199 LYS A 200 -1 O THR A 199 N ILE A 173 SHEET 1 AC 2 LEU A 182 LEU A 184 0 SHEET 2 AC 2 VAL A 190 ILE A 192 -1 O LYS A 191 N PHE A 183 LINK ZN ZN A 502 NE2 HIS A 93 1555 1555 2.15 LINK ZN ZN A 502 O4 TLA A 503 1555 1555 2.00 LINK ZN ZN A 502 SG CYS A 212 1555 1555 2.33 LINK ZN ZN A 502 SG CYS A 255 1555 5555 2.33 SITE 1 AC1 16 ARG A 57 LEU A 59 CYS A 67 ALA A 80 SITE 2 AC1 16 LYS A 82 LEU A 130 GLU A 131 CYS A 133 SITE 3 AC1 16 ARG A 134 ARG A 136 SER A 137 GLU A 140 SITE 4 AC1 16 GLY A 180 PHE A 183 ASP A 194 HOH A2048 SITE 1 AC2 4 HIS A 93 CYS A 212 CYS A 255 TLA A 503 SITE 1 AC3 7 LYS A 91 HIS A 93 GLN A 94 LYS A 97 SITE 2 AC3 7 CYS A 212 SER A 254 ZN A 502 CRYST1 66.595 66.595 154.035 90.00 90.00 120.00 P 32 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015016 0.008670 0.000000 0.00000 SCALE2 0.000000 0.017339 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006492 0.00000